Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)

G. Somlo; H. Xie; J. T. Vermeulen; R. F. Manges; P. M. Voorhees; P. Sonneveld; R. Z. Orlowski; S. Zweegman; M. Munteanu; S. Jagannath

doi:https://doi.org/10.1200/jco.2008.26.15_suppl.8593

Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)

G. Somlo, H. Xie, J. T. Vermeulen, R. F. Manges, P. M. Voorhees, P. Sonneveld, R. Z. Orlowski, S. Zweegman, M. Munteanu, S. Jagannath

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	8593-8593
Number of pages	1
Journal	Journal of clinical oncology
Volume	26
Issue number	15_suppl
DOIs	https://doi.org/10.1200/jco.2008.26.15_suppl.8593
Publication status	Published - 24 Feb 2017

Access to Document

https://doi.org/10.1200/jco.2008.26.15_suppl.8593

http://www.mendeley.com/research/phase-ii-study-evaluating-efficacy-safety-cnto328-combination-dexamethasone-patients-relapsedrefract

Cite this

Somlo, G., Xie, H., Vermeulen, J. T., Manges, R. F., Voorhees, P. M., Sonneveld, P., Orlowski, R. Z., Zweegman, S., Munteanu, M., & Jagannath, S. (2017). Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM). Journal of clinical oncology, 26(15_suppl), 8593-8593. https://doi.org/10.1200/jco.2008.26.15_suppl.8593

@article{181f2a73e3814e31af57d672bc54bce9,

title = "Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)",

author = "G. Somlo and H. Xie and Vermeulen, {J. T.} and Manges, {R. F.} and Voorhees, {P. M.} and P. Sonneveld and Orlowski, {R. Z.} and S. Zweegman and M. Munteanu and S. Jagannath",

year = "2017",

month = feb,

day = "24",

doi = "https://doi.org/10.1200/jco.2008.26.15_suppl.8593",

language = "English",

volume = "26",

pages = "8593--8593",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15_suppl",

}

Somlo, G, Xie, H, Vermeulen, JT, Manges, RF, Voorhees, PM, Sonneveld, P, Orlowski, RZ, Zweegman, S, Munteanu, M & Jagannath, S 2017, 'Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)', Journal of clinical oncology, vol. 26, no. 15_suppl, pp. 8593-8593. https://doi.org/10.1200/jco.2008.26.15_suppl.8593

TY - JOUR

T1 - Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)

AU - Somlo, G.

AU - Xie, H.

AU - Vermeulen, J. T.

AU - Manges, R. F.

AU - Voorhees, P. M.

AU - Sonneveld, P.

AU - Orlowski, R. Z.

AU - Zweegman, S.

AU - Munteanu, M.

AU - Jagannath, S.

PY - 2017/2/24

Y1 - 2017/2/24

U2 - https://doi.org/10.1200/jco.2008.26.15_suppl.8593

DO - https://doi.org/10.1200/jco.2008.26.15_suppl.8593

M3 - Article

SN - 0732-183X

VL - 26

SP - 8593

EP - 8593

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 15_suppl

ER -